Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

6 Analysts Have This to Say About Ansys

Analysts have provided the following ratings for Ansys (NASDAQ:ANSS) within the last quarter:

Benzinga

Analyst Ratings for Playtika Holding

Analysts have provided the following ratings for Playtika Holding (NASDAQ:PLTK) within the last quarter:

Benzinga

9 Analysts Have This to Say About T. Rowe Price Gr

Within the last quarter, T. Rowe Price Gr (NASDAQ:TROW) has observed the following analyst ratings:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

This Is What Whales Are Betting On ASML Holding

A whale with a lot of money to spend has taken a noticeably bearish stance on ASML Holding. Looking at options history for ASML Holding (NASDAQ:ASML) we detected 11 strange trades.

Benzinga

What 4 Analyst Ratings Have To Say About Biomarin Pharmaceutical

Analysts have provided the following ratings for Biomarin Pharmaceutical (NASDAQ:BMRN) within the last quarter:

Benzinga

5 Value Stocks In The Real Estate Sector

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

HC Wainwright Sees This Small-Cap Biotech As Undervalued, Underappreciated

At the European Hematology Association (EHA) meeting, Oncternal Therapeutics Inc (NASDAQ:ONCT) presented initial preclinical results of Oncternal's ROR1 CAR containing the antigen-binding region of zilovertamab. The data showed that The ROR1 CAR mediated target recognition and cell activation when expressed in either T cells or NK cells. Also, ROR1 CAR-T cells demonstrated dose-dependent anti-tumor…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Earnings Preview: High Tide

High Tide (NASDAQ:HITI) is set to give its latest quarterly earnings report on Tuesday, 2022-06-14. Here's what investors need to know before the announcement. Analysts estimate that High Tide will report an earnings per share (EPS) of $-0.03.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2022

Upgrades

Benzinga

Earnings Outlook For RF Industries

RF Industries (NASDAQ:RFIL) is set to give its latest quarterly earnings report on Tuesday, 2022-06-14. Here's what investors need to know before the announcement. Analysts estimate that RF Industries will report an earnings per share (EPS) of $0.07.

Benzinga

Here's How Much $1000 Invested In Enphase Energy 10 Years Ago Would Be Worth Today

Enphase Energy (NASDAQ:ENPH) has outperformed the market over the past 10 years by 27.59% on an annualized basis producing an average annual return of 38.44%. Currently, Enphase Energy has a market capitalization of $24.47 billion.

Benzinga

Here's How Mizuho Views AMD, Nvidia, Qualcomm

Mizuho analyst Vijay Rakesh included Gigabyte, a distributor of GPUs and a motherboard OEM, and Zhen Ding, a leading PCB supplier in coverage post-Asia tech series checks.

Benzinga

Earnings Outlook For Motorcar Parts of America

Motorcar Parts of America (NASDAQ:MPAA) is set to give its latest quarterly earnings report on Tuesday, 2022-06-14. Here's what investors need to know before the announcement. Analysts estimate that Motorcar Parts of America will report an earnings per share (EPS) of $0.47.

Benzinga

Journey Medical Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Journey Medical's (NASDAQ:DERM) reported sales totaled $23.30 million. Despite a 93.66% increase in earnings, the company posted a loss of $1.38 million.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

BRP Group's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, BRP Group (NASDAQ:BRP) earned $44.84 million, a 200.97% increase from the preceding quarter. BRP Group also posted a total of $242.85 million in sales, a 52.54% increase since Q4.

Benzinga

The RealReal's Return On Capital Employed Insights

The RealReal (NASDAQ:REAL) brought in sales totaling $146.70 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 10.0%, resulting in a loss of $57.41 million.

Benzinga

Sera Prognostics Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Sera Prognostics's (NASDAQ:SERA) reported sales totaled $38.00 thousand. Despite a 2.21% increase in earnings, the company posted a loss of $12.21 million.

Benzinga

BTRS Holdings Earnings Perspective: Return On Capital Employed

Benzinga Pro data, BTRS Holdings (NASDAQ:BTRS) reported Q1 sales of $45.63 million. Earnings fell to a loss of $29.03 million, resulting in a 76.18% decrease from last quarter.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why AMD Stock Is Trading Lower Today

Advanced Micro Devices Inc (NASDAQ: AMD) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Benzinga

Revance Therapeutics's Return On Capital Employed Insights

Benzinga Pro data, Revance Therapeutics (NASDAQ:RVNC) reported Q1 sales of $25.26 million. Earnings fell to a loss of $64.34 million, resulting in a 1.97% decrease from last quarter.

Benzinga

NanoString Technologies Earnings Perspective: Return On Capital Employed

Benzinga Pro data, NanoString Technologies (NASDAQ:NSTG) reported Q1 sales of $31.08 million. Earnings fell to a loss of $39.50 million, resulting in a 34.99% decrease from last quarter.

Benzinga

Why Microsoft Stock Is Moving Lower Today

Microsoft Corp (NASDAQ: MSFT) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Benzinga

5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.

Benzinga

Looking Into Xenon Pharmaceuticals's Return On Capital Employed

According to Benzinga Pro data, during Q1, Xenon Pharmaceuticals (NASDAQ:XENE) posted sales of $8.77 million. Earnings were up 23.06%, but Xenon Pharmaceuticals still reported an overall loss of $19.67 million.

Benzinga

InnovAge Holding Earnings Perspective: Return On Invested Capital

Benzinga Pro data, InnovAge Holding (NASDAQ:INNV) reported Q3 sales of $177.36 million. Earnings fell to a loss of $3.16 million, resulting in a 385.53% decrease from last quarter.

1 … 439 440 441 442

People

Vijay Rakesh

43 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.